These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31635287)
1. Embelin as a Novel Inhibitor of PKC in the Prevention of Platelet Activation and Thrombus Formation. Li JY; Chen RJ; Huang LT; Lee TY; Lu WJ; Lin KH J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31635287 [TBL] [Abstract][Full Text] [Related]
2. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Ahn KS; Sethi G; Aggarwal BB Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156 [TBL] [Abstract][Full Text] [Related]
3. Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism. Yen TL; Wu MP; Chung CL; Yang WB; Jayakumar T; Geraldine P; Chou CM; Chang CY; Lu WJ; Sheu JR J Biomed Sci; 2016 Feb; 23():26. PubMed ID: 26887315 [TBL] [Abstract][Full Text] [Related]
4. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways. Lien LM; Lin KH; Huang LT; Tseng MF; Chiu HC; Chen RJ; Lu WJ Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704925 [TBL] [Abstract][Full Text] [Related]
5. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells. Prabhu KS; Siveen KS; Kuttikrishnan S; Iskandarani A; Tsakou M; Achkar IW; Therachiyil L; Krishnankutty R; Parray A; Kulinski M; Merhi M; Dermime S; Mohammad RM; Uddin S PLoS One; 2017; 12(7):e0180895. PubMed ID: 28704451 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases. Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266 [TBL] [Abstract][Full Text] [Related]
7. Prevention of arterial thrombosis by nobiletin: in vitro and in vivo studies. Lu WJ; Lin KC; Liu CP; Lin CY; Wu HC; Chou DS; Geraldine P; Huang SY; Hsieh CY; Sheu JR J Nutr Biochem; 2016 Feb; 28():1-8. PubMed ID: 26878777 [TBL] [Abstract][Full Text] [Related]
8. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo. Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801 [TBL] [Abstract][Full Text] [Related]
9. Development of response surface methodology for optimization of extraction parameters and quantitative estimation of embelin from Embelia ribes Burm by high performance liquid chromatography. Alam MS; Damanhouri ZA; Ahmad A; Abidin L; Amir M; Aqil M; Khan SA; Mujeeb M Pharmacogn Mag; 2015 May; 11(Suppl 1):S166-72. PubMed ID: 26109763 [TBL] [Abstract][Full Text] [Related]
10. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling. Park N; Baek HS; Chun YJ PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation. Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683 [TBL] [Abstract][Full Text] [Related]
12. Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation. Brandes LJ; Gerrard JM; Bogdanovic RP; Lint DW; Reid RE; LaBella FS Cancer Res; 1988 Jul; 48(14):3954-8. PubMed ID: 3164253 [TBL] [Abstract][Full Text] [Related]
13. Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis. Holly SP; Gera N; Wang P; Wilson A; Guan Z; Lin L; Cooley B; Alfar HR; Patil RG; Piatt R; Leisner TM; Bergmeier W; Majumder R; Parise LV Blood Adv; 2019 Nov; 3(22):3818-3828. PubMed ID: 31770438 [TBL] [Abstract][Full Text] [Related]
14. Embelin: A multifaceted anticancer agent with translational potential in targeting tumor progression and metastasis. Kamath AJ; Chandy AS; Joseph AA; Gorantla JN; Donadkar AD; Nath LR; Sharifi-Rad J; Calina D EXCLI J; 2023; 22():1311-1329. PubMed ID: 38234968 [TBL] [Abstract][Full Text] [Related]
15. Guanosine exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling. Fuentes F; Alarcón M; Badimon L; Fuentes M; Klotz KN; Vilahur G; Kachler S; Padró T; Palomo I; Fuentes E Int J Cardiol; 2017 Dec; 248():294-300. PubMed ID: 28811090 [TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Sheu JR; Fong TH; Liu CM; Shen MY; Chen TL; Chang Y; Lu MS; Hsiao G Br J Pharmacol; 2004 Sep; 143(1):193-201. PubMed ID: 15289295 [TBL] [Abstract][Full Text] [Related]
17. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase. Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631 [TBL] [Abstract][Full Text] [Related]
18. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation. Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154 [TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma. Willars GB; Challiss RA; Stuart JA; Nahorski SR Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):905-13. PubMed ID: 8670170 [TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo. Lien LM; Chen ZC; Chung CL; Yen TL; Chiu HC; Chou DS; Huang SY; Sheu JR; Lu WJ; Lin KH Eur J Pharmacol; 2014 Aug; 737():159-67. PubMed ID: 24836986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]